Significant Ownership of Ph.D. Jay R. Luly

Signature - Title
/s/ Jay R. Luly, Ph.D. - Jay R. Luly, Ph.D.
Location
Watertown, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Ph.D. Jay R. Luly.

Notify me when Ph.D. Jay R. Luly files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Ph.D. Jay R. Luly

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ENTA Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share 7.7% $7,904,778 1,703,616 Jay R. Luly, Ph.D. 12 Feb 2025

Schedules 13D/G Reported by Ph.D. Jay R. Luly:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.